Surgeons Analysed Artery Plaque From 304 Patients. More Than Half Contained Plastic.

Microplastics have been detected in blood, placenta, lung tissue and stool. Most of that work established presence without establishing consequence. A 2024 study in the New England Journal of Medicine went further.

Researchers collected carotid plaque removed during endarterectomy — a procedure that strips atherosclerotic material from the carotid artery — from 304 patients, and analysed the excised tissue for polymer content.

Polyethylene was detected in 58% of samples. PVC was found in 12%. Electron microscopy showed jagged particles visible inside macrophages, the immune cells that populate atherosclerotic plaque.

Patients whose plaque contained detectable plastics went on to experience more myocardial infarctions, strokes and deaths over a follow-up period of approximately 34 months than patients whose plaque did not.

That is a genuinely arresting result, and it needs holding carefully.

Everyone in this study already had carotid artery disease severe enough to warrant surgery. This is not a general population sample, and the finding says nothing about whether microplastics initiate atherosclerosis — only about what was found in plaque that already existed. The outcome analysis rests on a single cohort of 257 patients with complete follow-up, which is modest for an outcomes study.

Contamination during collection, handling and analysis is the central methodological worry in all microplastics research, since the laboratory environment, the surgical setting and the equipment itself all contain polymers. The authors took precautions and reported them, but the field does not yet have fully standardised protocols, and contamination cannot be definitively excluded.

Most importantly, the association may not be causal in the direction it appears. Plastic-containing plaque may simply be more inflamed plaque, and inflammation independently predicts cardiovascular events. Particles may accumulate preferentially in unstable, macrophage-rich lesions rather than driving instability themselves. The study design cannot separate these possibilities.

The reasonable conclusion is that this is the strongest evidence to date that microplastic accumulation in human vascular tissue is associated with clinical outcomes, and that this is a serious finding warranting substantial further investigation — not a demonstrated causal mechanism.

One thing worth stating plainly, because the supplement market has already moved: nothing has been shown to remove microplastics from human tissue. No food, no supplement, no protocol, no cleanse. Any product claiming otherwise is selling something the evidence does not support. Reducing ongoing exposure — less bottled water, less heating of food in plastic containers, better indoor air filtration — is reasonable on precautionary grounds, but it is not the same as clearance.

Why this matters for tracking: there is no consumer test for tissue microplastic burden, and there will not be one soon. What is measurable, and what this study is actually about, is cardiovascular risk. If this finding concerns you, the productive response is to track the vascular markers that already have established interpretations and established interventions — ApoB, Lp(a), hs-CRP and blood pressure — rather than waiting for a plastics assay that does not exist.